• 7455 Citations
  • 36 h-Index
1987 …2024
If you made any changes in Pure these will be visible here soon.

Research Outputs 1987 2019

2015

Clinical perspectives: Practical insights from clinical experience with cabazitaxel in Australia

Parente, P., Gurney, H., Ng, S. & Bahre, M., 1 Sep 2015, In : Asia-Pacific Journal of Clinical Oncology. 11, 3, p. 199-207 9 p.

Research output: Contribution to journalReview articleResearchpeer-review

Prostatic Neoplasms
Castration
docetaxel
Nurses
Therapeutics

Describing patterns of care in pancreatic cancer a population-based study: a population-based study

Burmeister, E. A., OʼConnell, D. L., Beesley, V. L., Goldstein, D., Gooden, H. M., Janda, M., Jordan, S. J., Merrett, N. D., Payne, M. E., Wyld, D. K., Neale, R. E. & Pancreatic Cancer Patterns of Care Study Group, Nov 2015, In : Pancreas. 44, 8, p. 1259-65 7 p.

Research output: Contribution to journalArticleResearchpeer-review

Pancreatic Neoplasms
Population
Adjuvant Chemotherapy
Neoplasms
Medical Records

Doctor-patient communication: a study of Australian ethnic urological cancer patients

Cerimagic, S., Ahmadi, N., Gurney, H. & Patel, M. I., 1 Jun 2015, In : International Journal of Human Rights in Healthcare. 8, 2, p. 82-91 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Urologic Neoplasms
cancer
Communication
communication
illness

Nivolumab versus everolimus in advanced renal-cell carcinoma

Motzer, R. J., Escudier, B., McDermott, D. F., George, S., Hammers, H. J., Srinivas, S., Tykodi, S. S., Sosman, J. A., Procopio, G., Plimack, E. R., Castellano, D., Choueiri, T. K., Gurney, H., Donskov, F., Bono, P., Wagstaff, J., Gauler, T. C., Ueda, T., Tomita, Y., Schutz, F. A. & 8 othersKollmannsberger, C., Larkin, J., Ravaud, A., Simon, J. S., Xu, L. A., Waxman, I. M., Sharma, P. & CheckMate 025 Investigators, 5 Nov 2015, In : New England Journal of Medicine. 373, 19, p. 1803-1813 11 p.

Research output: Contribution to journalArticleResearchpeer-review

Renal Cell Carcinoma
Confidence Intervals
Survival
Everolimus
nivolumab

Positive lifestyle changes following urological cancer diagnoses: an Australian interview based study

Cerimagic, S., Ahmadi, N., Gurney, H., Hossack, T. & Patel, M. I., 1 Jun 2015, In : International Journal of Human Rights in Healthcare. 8, 2, p. 110-119 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Urologic Neoplasms
Life Style
cancer
Interviews
interview
2014

Accelerated BEP for metastatic germ cell tumours: A multicenter phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)

Grimison, P. S., Stockler, M. R., Chatfield, M., Thomson, D. B., Gebski, V., Friedlander, M., Boland, A. L., Houghton, B., Gurney, H., Rosenthal, M., Singhal, N., Kichenadasse, G., Wong, S. S., Lewis, C. R., Vasey, P. A. & Toner, G. C., 2014, In : Annals of Oncology. 25, 1, p. 143-148 6 p., mdt369.

Research output: Contribution to journalArticleResearchpeer-review

Urogenital Neoplasms
Germ Cell and Embryonal Neoplasms
Bleomycin
Etoposide
New Zealand

Association analysis of genetic polymorphisms in genes related to sunitinib pharmacokinetics, specifically clearance of sunitinib and SU12662

Diekstra, M. H. M., Klümpen, H. J., Lolkema, M. P. J. K., Yu, H., Kloth, J. S. L., Gelderblom, H., Van Schaik, R. H. N., Gurney, H., Swen, J. J., Huitema, A. D. R., Steeghs, N. & Mathijssen, R. H. J., 2014, In : Clinical Pharmacology and Therapeutics. 96, 1, p. 81-89 9 p.

Research output: Contribution to journalArticleResearchpeer-review

Genetic Polymorphisms
Pharmacokinetics
Single Nucleotide Polymorphism
Cytochrome P-450 CYP3A
Genes

Challenges in the sequencing of therapies for the management of metastatic castration-resistant prostate cancer

Parente, P., Parnis, F. & Gurney, H., 2014, In : Asia-Pacific Journal of Clinical Oncology. 10, 3, p. 205-215 11 p.

Research output: Contribution to journalReview articleResearchpeer-review

Castration
Prostatic Neoplasms
docetaxel
Drug Therapy
Radium

Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer

Lin, H. M., Castillo, L., Mahon, K. L., Chiam, K., Lee, B. Y., Nguyen, Q., Boyer, M. J., Stockler, M. R., Pavlakis, N., Marx, G., Mallesara, G., Gurney, H., Clark, S. J., Swarbrick, A., Daly, R. J. & Horvath, L. G., 13 May 2014, In : British Journal of Cancer. 110, 10, p. 2462-2471 10 p.

Research output: Contribution to journalArticleResearchpeer-review

docetaxel
Castration
MicroRNAs
Prostatic Neoplasms
Drug Therapy

Methylated Glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer

Mahon, K. L., Qu, W., Devaney, J., Paul, C., Castillo, L., Wykes, R. J., Chatfield, M. D., Boyer, M. J., Stockler, M. R., Marx, G., Gurney, H., Mallesara, G., Molloy, P. L., Horvath, L. G. & Clark, S. J., 28 Oct 2014, In : British Journal of Cancer. 111, 9, p. 1802-1809 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
Glutathione Transferase
Genetic Markers
Epigenomics
Prostatic Neoplasms
Drug Therapy

Predictive value of CYP3A and ABCB1 phenotyping probes for the pharmacokinetics of sunitinib: The ClearSun study

Kloth, J. S. L., Klümpen, H. J., Yu, H., Eechoute, K., Samer, C. F., Kam, B. L. R., Huitema, A. D. R., Daali, Y., Zwinderman, A. H., Balakrishnar, B., Bennink, R. J., Wong, M., Schellens, J. H. M., Mathijssen, R. H. J. & Gurney, H., Mar 2014, In : Clinical Pharmacokinetics. 53, 3, p. 261-269 9 p.

Research output: Contribution to journalArticleResearchpeer-review

Cytochrome P-450 CYP3A
Pharmacokinetics
Midazolam
Phenotype
Nonlinear Dynamics

Racial disparity in metastatic renal cell cancer: The pharmaco-anthropology of sunitinib

Zhang, A. & Gurney, H., 2014, In : Asia-Pacific Journal of Clinical Oncology. 10, 3, p. 197-199 3 p.

Research output: Contribution to journalEditorialResearch

Use of targeted therapies for advanced renal cell carcinoma in the asia-pacific region: opinion statement from China, Japan, Taiwan, Korea, and Australia

Ye, D., Eto, M., Chung, J. S., Kimura, G., Chang, W. C., Chang, Y. H., Pang, S. T., Lee, J. L., Niu, Y., Gurney, H. & Uemura, H., 2014, In : Clinical Genitourinary Cancer. 12, 4, p. 225-233 9 p.

Research output: Contribution to journalReview articleResearchpeer-review

Korea
Taiwan
Renal Cell Carcinoma
China
Japan
2013

Factors predicting endoxifen levels in breast cancer patients taking standard-dose tamoxifen and following dose escalation

Fox, P., Gao, B., Balakrishnar, B., Menzies, A. M., Gebski, V., Provan, P., Coulter, S., Liddle, C., Hui, R., Kefford, R., Lynch, J., Wilcken, N., Balleine, R. L. & Gurney, H., 1 Jul 2013, In : Asia-Pacific Journal of Clinical Oncology. 9, Supplement 2, p. 45-45 1 p.

Research output: Contribution to journalMeeting abstractResearchpeer-review

Factors predicting endoxifen levels in breast cancer patients taking standard-dose tamoxifen and following dose escalation

Fox, P., Gao, B., Balakrishnar, B., Menzies, A. M., Yeap, S. H., Ali, S. S., Gebski, V., Provan, P., Coulter, S., Liddle, C., Hui, R., Kefford, R., Lynch, J., Wilcken, N., Balleine, R. L. & Gurney, H., 20 May 2013, In : Journal of Clinical Oncology. 31, 15 supplement, p. 1-1 1 p., 543.

Research output: Contribution to journalMeeting abstractResearchpeer-review

Functional analysis of novel polymorphisms in the human SLCO1A2 gene that encodes the transporter OATP1A2

Zhou, F., Zheng, J., Zhu, L., Jodal, A., Cui, P. H., Wong, M., Gurney, H., Church, W. B. & Murray, M., 2013, In : AAPS Journal. 15, 4, p. 1099-1108 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Single Nucleotide Polymorphism
Biotinylation
Molecular Models
Membranes
HEK293 Cells

Impact of baseline and nadir neutrophil index in non-small cell lung cancer and ovarian cancer patients: Assessment of chemotherapy for resolution of unfavourable neutrophilia

Carus, A., Gurney, H., Gebski, V., Harnett, P., Hui, R., Kefford, R., Wilcken, N., Ladekarl, M., von der Maase, H. & Donskov, F., 2013, In : Journal of Translational Medicine. 11, p. 189 1 p.

Research output: Contribution to journalArticleResearchpeer-review

Chemotherapy
Neutropenia
Non-Small Cell Lung Carcinoma
Ovarian Neoplasms
Neutrophils

Primary treatment of the prostate improves local palliation in men who ultimately develop castrate-resistant prostate cancer

Won, A. C. M., Gurney, H., Marx, G., De Souza, P. & Patel, M. I., Aug 2013, In : BJU international. 112, 4, p. E250-E255 6 p.

Research output: Contribution to journalArticleResearchpeer-review

Prostate
Prostatic Neoplasms
Prostatectomy
Radiotherapy
Therapeutics

The prevalence and correlates of supportive care needs in testicular cancer survivors: A cross-sectional study

Smith, A., King, M., Butow, P., Luckett, T., Grimison, P., Toner, G. C., Stockler, M., Hovey, E., Stubbs, J., Hruby, G., Gurney, H., Turner, S., Alam, M., Cox, K. & Olver, I., Nov 2013, In : Psycho-Oncology. 22, 11, p. 2557-2564 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Testicular Neoplasms
Survivors
Cross-Sectional Studies
Psychology
Survival Rate
2012

Accelerated BEP for metastatic germ cell tumors: combined analysis of Australian and UK phase I/II trials

Grimison, P. S., Chatfield, M. D., Mazhar, D., Toner, G. C., Chester, J. D., Stockler, M. R., Stark, D. P., Thomson, D. B., Shamash, J., Friedlander, M., White, J., Gebski, V., Wason, J., Boland, A. L., Rimmer, Y. L., McDonald, A., Gurney, H., Rosenthal, M., Singhal, N., Williams, M. V. & 2 othersAustralian New Zealand Urogenital & West Anglia Cancer Research Network, 20 May 2012, In : Journal of Clinical Oncology. 30, 15 supplement, p. 4531-4531 1 p.

Research output: Contribution to journalMeeting abstractResearch

Concomitant CYP2D6 inhibitor use and plasma metabolite levels in breast cancer patients treated with tamoxifen

Fox, P., Balakrishnar, B., Menzies, A., Liddle, C., Coulter, S., Provan, P., Gebski, V., Hui, R., Kefford, R., Wilcken, N., Balleine, R. & Gurney, H., 31 Jul 2012, In : Asia-Pacific Journal of Clinical Oncology. 8, Supplement 2, p. 52-52 1 p.

Research output: Contribution to journalMeeting abstractResearchpeer-review

CYP2D6 genotype and adverse effects as indicators of plasma endoxifen in breast cancer patients taking tamoxifen

Balakrishnar, B., Menzies, A. M., Ali, S. S., Yeap, S. H., Gao, B., Liddle, C., Coulter, S., Provan, P., Gebski, V., Hui, R., Kefford, R., Wilcken, N., Balleine, R. L. & Gurney, H., 20 May 2012, In : Journal of Clinical Oncology. 30, Supplement 15, p. 550-550 1 p.

Research output: Contribution to journalMeeting abstractResearchpeer-review

Emerging and second line therapies for the management of metastatic castration-resistant prostate cancer: The Australian perspective

Parente, P., Parnis, F. & Gurney, H., 2012, In : Asia-Pacific Journal of Clinical Oncology. 8, 1, p. 31-42 12 p.

Research output: Contribution to journalReview articleResearchpeer-review

docetaxel
Castration
Prostatic Neoplasms
Therapeutics
Drug Therapy

Evidence for therapeutic drug monitoring of targeted anticancer therapies

Gao, B., Yeap, S., Clements, A., Balakrishnar, B., Wong, M. & Gurney, H., 10 Nov 2012, In : Journal of Clinical Oncology. 30, 32, p. 4017-4025 9 p.

Research output: Contribution to journalReview articleResearchpeer-review

Drug Monitoring
Pharmacokinetics
Pharmaceutical Preparations
Immunosuppressive Agents
Intravenous Injections
2011

Accelerated BEP for advanced germ cell tumors: an Australian multicenter phase I/II trial.

Grimison, P. S., Thomson, D. B., Stockler, M. R., Chatfield, M. D., Friedlander, M., Gebski, V., Boland, A. L., Houghton, B. B., Gurney, H., Rosenthal, M., Singhal, N., Kichenadasse, G., Wong, S. S., Lewis, C. R., Vasey, P. A., Toner, G. C. & Australian New Zealand Urogenital, 20 May 2011, In : Journal of Clinical Oncology. 29, 15 supplement, p. 4561-4561 1 p.

Research output: Contribution to journalMeeting abstractResearch

Carboplatin-paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer

Lee, C. K., Gurney, H., Brown, C., Sorio, R., Donadello, N., Tulunay, G., Meier, W., Bacon, M., Maenpaa, J., Petru, E., Reed, N., Gebski, V., Pujade-Lauraine, E., Lord, S., Simes, R. J. & Friedlander, M., 26 Jul 2011, In : British Journal of Cancer. 105, 3, p. 360-365 6 p.

Research output: Contribution to journalArticleResearchpeer-review

Carboplatin
Leukopenia
Paclitaxel
Ovarian Neoplasms
Disease-Free Survival

Environmental and genetic factors affecting transport of imatinib by OATP1A2

Eechoute, K., Franke, R. M., Loos, W. J., Scherkenbach, L. A., Boere, I., Verweij, J., Gurney, H., Kim, R. B., Tirona, R. G., Mathijssen, R. H. J. & Sparreboom, A., 2011, In : Clinical Pharmacology and Therapeutics. 89, 6, p. 816-820 5 p.

Research output: Contribution to journalArticleResearchpeer-review

Drug Interactions
Duodenum
Biological Availability
Anions
Peptides

Metformin in prostate cancer: Two for the price of one

Clements, A., Gao, B., Yeap, S. H. O., Wong, M. K. Y., Ali, S. S. & Gurney, H., Dec 2011, In : Annals of Oncology. 22, 12, p. 2556-2560 5 p., mdr037.

Research output: Contribution to journalReview articleResearchpeer-review

Metformin
Prostatic Neoplasms
Androgens
Antineoplastic Agents
Clinical Trials

Moving towards dose individualization of tyrosine kinase inhibitors

Klümpen, H. J., Samer, C. F., Mathijssen, R. H. J., Schellens, J. H. M. & Gurney, H., Jun 2011, In : Cancer Treatment Reviews. 37, 4, p. 251-260 10 p.

Research output: Contribution to journalReview articleResearchpeer-review

Protein-Tyrosine Kinases
Pharmacokinetics
Biomarkers
Molecular Targeted Therapy
Therapeutics

Paraneoplastic hepatic dysfunction in metastatic prostate cancer: the role of cytokine dysregulation

Nguyen, V., Gurney, H. & Van Der Poorten, D., 10 Jan 2011, In : Journal of Clinical Oncology. 29, 2, p. 1-3 3 p.

Research output: Contribution to journalArticleResearchpeer-review

The effect of pulmonary function testing on bleomycin dosing in germ cell tumors

Houghton, B. B., Grimison, P. S., Toner, G. C., Chatfield, M., Thomson, D. B., Friedlander, M., Gebski, V., Rosenthal, M., Gurney, H. & Stockler, M., 1 Mar 2011, In : Journal of Clinical Oncology. 29, 7 supplement, p. 227-227 1 p.

Research output: Contribution to journalMeeting abstractResearch

2010

Comparison of two standard chemotherapy regimens for good-prognosis germ cell tumors: Updated analysis of a randomized trial

Grimison, P. S., Stockler, M. R., Thomson, D. B., Olver, I. N., Harvey, V. J., Gebski, V. J., Lewis, C. R., Levi, J. A., Boyer, M. J., Gurney, H., Craft, P., Boland, A. L., Simes, R. J. & Toner, G. C., 18 Aug 2010, In : Journal of the National Cancer Institute. 102, 16, p. 1253-1262 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Germ Cell and Embryonal Neoplasms
Bleomycin
Etoposide
Drug Therapy
Cisplatin

Inhibitors of mTOR

Klümpen, H. J., Beijnen, J. H., Gurney, H. & Schellens, J. H. M., Dec 2010, In : Oncologist. 15, 12, p. 1262-1269 8 p.

Research output: Contribution to journalReview articleResearchpeer-review

Sirolimus
Pharmaceutical Preparations
Pharmacogenetics
Drug Interactions
Renal Cell Carcinoma

Population pharmacokinetics of melphalan in patients with multiple myeloma undergoing high dose therapy

Nath, C. E., Shaw, P. J., Trotman, J., Zeng, L., Duffull, S. B., Hegarty, G., McLachlan, A. J., Gurney, H., Kerridge, I., Kwan, Y. L., Presgrave, P., Tiley, C., Joshua, D. & Earl, J., May 2010, In : British Journal of Clinical Pharmacology. 69, 5, p. 484-497 14 p.

Research output: Contribution to journalArticleResearchpeer-review

Melphalan
Multiple Myeloma
Pharmacokinetics
Population
Area Under Curve
2009

An open-label, single-arm phase two trial of gefitinib in patients with advanced or metastatic castration-resistant prostate cancer

Pezaro, C., Rosenthal, M. A., Gurney, H., Davis, I. D., Underhill, C., Boyer, M. J., Kotasek, D., Solomon, B. & Toner, G. C., Aug 2009, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 32, 4, p. 338-341 4 p.

Research output: Contribution to journalArticleResearchpeer-review

Castration
Prostatic Neoplasms
Prostate-Specific Antigen
gefitinib
Epidermal Growth Factor Receptor

Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumors: updated analysis of a randomized trial with 8 years follow-up

Grimison, P. S., Stockler, M. R., Thomson, D. B., Olver, I. N., Harvey, V. J., Gurney, H., Lewis, C. R., Gebski, V. J., Boland, A. L., Toner, G. C. & Australia New Zealand Germ Cell, 20 May 2009, In : Journal of Clinical Oncology. 27, 15, p. 5016-5016 2 p.

Research output: Contribution to journalMeeting abstractResearch

Irinogenetics: How many stars are there in the sky?

Mathijssen, R. H. J. & Gurney, H., 1 Jun 2009, In : Journal of Clinical Oncology. 27, 16, p. 2578-2579 2 p.

Research output: Contribution to journalEditorialResearchpeer-review

2008

Dose calculation of anticancer drugs

Gao, B., Klumpen, H. J. & Gurney, H., Oct 2008, In : Expert Opinion on Drug Metabolism and Toxicology. 4, 10, p. 1307-1319 13 p.

Research output: Contribution to journalReview articleResearchpeer-review

Pharmaceutical Preparations
Drug Monitoring
Body Surface Area
Poisons
Therapeutic Uses

Improving outcomes for operable pancreatic cancer: is access to safer surgery the problem?

Chang, D. K., Merrett, N. D., Biankin, A. V. & NSW Pancreatic Cancer Network, Jul 2008, In : Journal of Gastroenterology and Hepatology (Australia). 23, 7 Pt 1, p. 1036-45 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Pancreatic Neoplasms
Pancreatectomy
Mortality
Group Psychotherapy
Survival

Increased detections of leptomeningeal presentations in men with hormone refractory prostate cancer: An effect of improved systemic therapy?

Lin, C., Turner, S., Gurney, H. & Peduto, A., Aug 2008, In : Journal of Medical Imaging and Radiation Oncology. 52, 4, p. 376-381 6 p.

Research output: Contribution to journalArticleResearchpeer-review

Prostatic Neoplasms
Hormones
Neoplasm Metastasis
Therapeutics
Natural History

Multinodular goitre: An unusual cause in a patient with acromegaly

Wong, V. W., Gurney, H. & Hazel, J. R., Sep 2008, In : Internal Medicine Journal. 38, 9, p. 742-743 2 p.

Research output: Contribution to journalLetterResearchpeer-review

Outcomes and predicting response in anaemic chemotherapy patients treated with epoetin alfa. A multicentre, 4-month, open-label study in Australia and New Zealand

Bell, D., Grimes, D., Gurney, H., Dalley, D., Blackwell, T., Fox, R. & Jeffery, M., Oct 2008, In : Internal Medicine Journal. 38, 10, p. 751-757 7 p.

Research output: Contribution to journalArticleResearchpeer-review

Epoetin Alfa
New Zealand
Drug Therapy
Reticulocytes
Erythropoietin

Transporter pumps and imatinib: A cause of pharmacokinetic resistance?

Klumpen, H. J., Liddle, C. & Gurney, H., Mar 2008, In : Cancer Biology and Therapy. 7, 3, p. 416-418 3 p.

Research output: Contribution to journalComment/opinionResearchpeer-review

2007

Allogeneic bone marrow transplant for refractory mediastinal germ cell tumour: Possible evidence of graft-versus-tumour effect

Goodwin, A., Gurney, H. & Gottlieb, D., Feb 2007, In : Internal Medicine Journal. 37, 2, p. 127-129 3 p.

Research output: Contribution to journalReview articleResearchpeer-review

Germ Cell and Embryonal Neoplasms
Bone Marrow
Transplants
Neoplasms
Homologous Transplantation

Death of a clinical trial: A speculative inclusion criterion gone wrong [3]

Rosenthal, M. A., Woo, H., Gurney, H., Copeman, M. & Zingarelli, G., Dec 2007, In : Internal Medicine Journal. 37, 12, p. 838-839 2 p.

Research output: Contribution to journalLetterResearchpeer-review

Imatinib disposition and ABCB1 (MDR1, P-glycoprotein) genotype

Gurney, H., Wong, M., Balleine, R. L., Rivory, L. P., McLachlan, A. J., Hoskins, J. M., Wilcken, N., Clarke, C. L., Mann, G. J., Collins, M., Delforce, S. E., Lynch, K. & Schran, H., 14 Jul 2007, In : Clinical Pharmacology and Therapeutics. 82, 1, p. 33-40 8 p.

Research output: Contribution to journalArticleResearchpeer-review

P-Glycoprotein
Genotype
Cytochrome P-450 CYP3A
Gastrointestinal Stromal Tumors
Homozygote

Obesity in dose calculation: A mouse or an elephant?

Gurney, H. & Shaw, R., 20 Oct 2007, In : Journal of Clinical Oncology. 25, 30, p. 4703-4704 2 p.

Research output: Contribution to journalEditorialResearchpeer-review

Sunitinib malate in the treatment of renal cell carcinoma and gastrointestinal stromal tumor: Recommendations for patient management

Desai, J., Gurney, H., Pavlakis, N., Mcarthur, G. A. & Davis, I. D., Dec 2007, In : Asia-Pacific Journal of Clinical Oncology. 3, 4, p. 167-176 10 p.

Research output: Contribution to journalReview articleResearchpeer-review

Gastrointestinal Stromal Tumors
Renal Cell Carcinoma
Hand-Foot Syndrome
Therapeutics
Lethargy
2006

Adverse effects to quality of life arising from treatment can recover with intermittent androgen suppression in men with prostate cancer

Spry, N. A., Kristjanson, L., Hooton, B., Hayden, L., Neerhut, G., Gurney, H., Corica, T., Korbel, E., Weinstein, S. & McCaul, K., May 2006, In : European Journal of Cancer. 42, 8, p. 1083-1092 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Androgens
Prostatic Neoplasms
Quality of Life
Testosterone
Therapeutics

Developing a new framework for dose calculation

Gurney, H., 1 Apr 2006, In : Journal of Clinical Oncology. 24, 10, p. 1489-1490 2 p.

Research output: Contribution to journalEditorialResearchpeer-review